SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001915967-22-000001
Filing Date
2022-08-08
Accepted
2022-08-08 17:26:38
Documents
4
Period of Report
2022-08-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_165999397839564.html 3  
1 FORM 3 wf-form3_165999397839564.xml 3 1769
2 JENNY YIP POA section16powerofattorney.htm EX-24 4643
3 YIP GRAPHIC 1 section16powerofattorney001.jpg GRAPHIC 222176
4 YIP GRAPHIC 2 section16powerofattorney002.jpg GRAPHIC 39110
  Complete submission text file 0001915967-22-000001.txt   367925
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Issuer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12400 HIGH BLUFF DR., STE. 600 SAN DIEGO CA 92130
Business Address
Yip Jenny C. (Reporting) CIK: 0001915967 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36754 | Film No.: 221145597